LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Book ; Thesis: Untersuchung über die Nährstoffversorgung an jungen Bundeswehrsoldaten

    Fink-Wagner, Antje-Henriette

    1985  

    Author's details Antje-Henriette Fink-Wagner
    Keywords Deutschland ; Soldat ; Ernährung
    Subject Nutrition ; Ernährungsstatus ; Ernährungszustand ; Legionär ; Soldaten
    Language German
    Size XIII, 183 S. : graph. Darst.
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Gießen, Univ., Diss., 1985
    HBZ-ID HT002825873
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Book ; Thesis: Untersuchung über die Nährstoffversorgung an jungen Bundeswehrsoldaten

    Fink-Wagner, Antje-Henriette

    1985  

    Author's details Antje-Henriette Fink-Wagner
    Keywords Deutschland ; Soldat ; Ernährung
    Subject Nutrition ; Ernährungsstatus ; Ernährungszustand ; Legionär ; Soldaten
    Language German
    Size XIII, 183 S. : graph. Darst.
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Gießen, Univ., Diss., 1985
    HBZ-ID HT002825873
    Database Catalogue ZB MED Nutrition, Environment, Agriculture

    More links

    Kategorien

  3. Article ; Online: A Charter to Improve Patient Care in Severe Asthma.

    Menzies-Gow, Andrew / Canonica, G-Walter / Winders, Tonya A / Correia de Sousa, Jaime / Upham, John W / Fink-Wagner, Antje-Henriette

    Advances in therapy

    2018  Volume 35, Issue 10, Page(s) 1485–1496

    Abstract: Severe asthma is a subtype of asthma that is difficult to treat and control. By conservative estimates, severe asthma affects approximately 5-10% of patients with asthma worldwide. Severe asthma impairs patients' health-related quality of life, and ... ...

    Abstract Severe asthma is a subtype of asthma that is difficult to treat and control. By conservative estimates, severe asthma affects approximately 5-10% of patients with asthma worldwide. Severe asthma impairs patients' health-related quality of life, and patients are at risk of life-threatening asthma attacks. Severe asthma also accounts for the majority of health care expenditures associated with asthma. Guidelines recommend that patients with severe asthma be referred to a specialist respiratory team for correct diagnosis and expert management. This is particularly important to ensure that they have access to newly available biologic treatments. However, many patients with severe asthma can suffer multiple asthma attacks and wait several years before they are referred for specialist care. As global patient advocates, we believe it is essential to raise awareness and understanding for patients, caregivers, health care professionals, and the public about the substantial impact of severe asthma and to create opportunities for improving patient care. Patients should be empowered to live a life free of symptoms and the adverse effects of traditional medications (e.g., oral corticosteroids), reducing hospital visits and emergency care, the loss of school and work days, and the constraints placed on their daily lives. Here we provide a Patient Charter for severe asthma, consisting of six core principles, to mobilize national governments, health care providers, payer policymakers, lung health industry partners, and patients/caregivers to address the unmet need and burden in severe asthma and ultimately work together to deliver meaningful improvements in care.
    Funding: AstraZeneca.
    MeSH term(s) Asthma/diagnosis ; Asthma/psychology ; Asthma/therapy ; Health Policy ; Humans ; Needs Assessment ; Patient Care Management/methods ; Patient Care Management/standards ; Quality Improvement/organization & administration ; Quality of Life ; Severity of Illness Index
    Language English
    Publishing date 2018-09-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632651-1
    ISSN 1865-8652 ; 0741-238X
    ISSN (online) 1865-8652
    ISSN 0741-238X
    DOI 10.1007/s12325-018-0777-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Thesis: Untersuchung über die Nährstoffversorgung an jungen Bundeswehrsoldaten

    Fink-Wagner, Antje-Henriette

    1985  

    Author's details Antje-Henriette Fink-Wagner
    Language German
    Size XIII, 183 S, graph. Darst, 21 cm
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Univ., Diss.--Giessen, 1985
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  5. Article ; Online: Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)

    Klimek, Ludger / Pfaar, Oliver / Worm, Margitta / Eiwegger, Thomas / Hagemann, Jan / Ollert, Markus / Untersmayr, Eva / Hoffmann-Sommergruber, Karin / Vultaggio, Alessandra / Agache, Ioana / Bavbek, Sevim / Bossios, Apostolos / Casper, Ingrid / Chan, Susan / Chatzipetrou, Alexia / Vogelberg, Christian / Firinu, Davide / Kauppi, Paula / Kolios, Antonios /
    Kothari, Akash / Matucci, Andrea / Palomares, Oscar / Szépfalusi, Zsolt / Pohl, Wolfgang / Hötzenecker, Wolfram / Rosenkranz, Alexander R / Bergmann, Karl-Christian / Bieber, Thomas / Buhl, Roland / Buters, Jeroen / Darsow, Ulf / Keil, Thomas / Kleine-Tebbe, Jörg / Lau, Susanne / Maurer, Marcus / Merk, Hans / Mösges, Ralph / Saloga, Joachim / Staubach, Petra / Jappe, Uta / Rabe, Klaus F / Rabe, Uta / Vogelmeier, Claus / Biedermann, Tilo / Jung, Kirsten / Schlenter, Wolfgang / Ring, Johannes / Chaker, Adam / Wehrmann, Wolfgang / Becker, Sven / Freudelsperger, Laura / Mülleneisen, Norbert / Nemat, Katja / Czech, Wolfgang / Wrede, Holger / Brehler, Randolf / Fuchs, Thomas / Tomazic, Peter-Valentin / Aberer, Werner / Fink-Wagner, Antje-Henriette / Horak, Fritz / Wöhrl, Stefan / Niederberger-Leppin, Verena / Pali-Schöll, Isabella / Roller-Wirnsberger, Regina / Spranger, Otto / Valenta, Rudolf / Akdis, Mübecell / Matricardi, Paolo M / Spertini, François / Khaltaev, Nicolai / Michel, Jean-Pierre / Nicod, Larent / Schmid-Grendelmeier, Peter / Idzko, Marco / Hamelmann, Eckard / Jakob, Thilo / Werfel, Thomas / Wagenmann, Martin / Taube, Christian / Jensen-Jarolim, Erika / Korn, Stephanie / Hentges, Francois / Schwarze, Jürgen / O Mahony, Liam / Knol, Edward F / Del Giacco, Stefano / Chivato Pérez, Tomás / Bousquet, Jean / Bedbrook, Anna / Zuberbier, Torsten / Akdis, Cezmi / Jutel, Marek

    Allergologie select

    2020  Volume 4, Page(s) 53–68

    Abstract: Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with allergic and atopy-associated diseases has faced major challenges. Recommendations for "social distancing" and the fear of patients becoming infected during a visit ...

    Abstract Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with allergic and atopy-associated diseases has faced major challenges. Recommendations for "social distancing" and the fear of patients becoming infected during a visit to a medical facility have led to a drastic decrease in personal doctor-patient contacts. This affects both acute care and treatment of the chronically ill. The immune response after SARS-CoV-2 infection is so far only insufficiently understood and could be altered in a favorable or unfavorable way by therapy with monoclonal antibodies. There is currently no evidence for an increased risk of a severe COVID-19 course in allergic patients. Many patients are under ongoing therapy with biologicals that inhibit type 2 immune responses via various mechanisms. There is uncertainty about possible immunological interactions and potential risks of these biologicals in the case of an infection with SARS-CoV-2.
    Materials and methods: A selective literature search was carried out in PubMed, Livivo, and the internet to cover the past 10 years (May 2010 - April 2020). Additionally, the current German-language publications were analyzed. Based on these data, the present position paper provides recommendations for the biological treatment of patients with allergic and atopy-associated diseases during the COVID-19 pandemic.
    Results: In order to maintain in-office consultation services, a safe treatment environment must be created that is adapted to the pandemic situation. To date, there is a lack of reliable study data on the care for patients with complex respiratory, atopic, and allergic diseases in times of an imminent infection risk from SARS-CoV-2. Type-2-dominant immune reactions, as they are frequently seen in allergic patients, could influence various phases of COVID-19, e.g., by slowing down the immune reactions. Theoretically, this could have an unfavorable effect in the early phase of a SARS-Cov-2 infection, but also a positive effect during a cytokine storm in the later phase of severe courses. However, since there is currently no evidence for this, all data from patients treated with a biological directed against type 2 immune reactions who develop COVID-19 should be collected in registries, and their disease courses documented in order to be able to provide experience-based instructions in the future.
    Conclusion: The use of biologicals for the treatment of bronchial asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, and spontaneous urticaria should be continued as usual in patients without suspected infection or proven SARS-CoV-2 infection. If available, it is recommended to prefer a formulation for self-application and to offer telemedical monitoring. Treatment should aim at the best possible control of difficult-to-control allergic and atopic diseases using adequate rescue and add-on therapy and should avoid the need for systemic glucocorticosteroids. If SARS-CoV-2 infection is proven or reasonably suspected, the therapy should be determined by weighing the benefits and risks individually for the patient in question, and the patient should be involved in the decision-making. It should be kept in mind that the potential effects of biologicals on the immune response in COVID-19 are currently not known. Telemedical offers are particularly desirable for the acute consultation needs of suitable patients.
    Keywords covid19
    Language English
    Publishing date 2020-09-07
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2893503-2
    ISSN 2512-8957 ; 2512-8957
    ISSN (online) 2512-8957
    ISSN 2512-8957
    DOI 10.5414/ALX02166E
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top